BEYOND LDL-CHOLESTEROL REDUCTION: EFFECT OF EZETIMIBE IN COMBINATION WITH ATORVASTATIN ON OXIDIZED LDL-CHOLESTEROL IN PATIENTS WITH CORONARY ARTERY DISEASE OR CORONARY ARTERY DISEASE EQUIVALENT

被引：0
|
作者：
Azar, Rabih R. [1 ]
Badaoui, Georges [1 ]
Sarkis, Antoine [1 ]
Azar, Mireille [1 ]
Aydanian, Hermine [1 ]
Harb, Serge [1 ]
Achkouty, Guy [1 ]
Kassab, Roland [1 ]
机构：
[1] Hotel Dieu France Hosp, Beirut, Lebanon
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2010年 / 55卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1019-100
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Effect of Ezetimibe/Atorvastatin Combination on Oxidized Low Density Lipoprotein Cholesterol in Patients With Coronary Artery Disease or Coronary Artery Disease Equivalent
    Azar, Rabih R.
    Badaoui, Georges
    Sarkis, Antoine
    Azar, Mireille
    Aydanian, Hermine
    Harb, Serge
    Achkouty, Guy
    Kassab, Roland
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2010, 106 (02): : 193 - 197
  • [2] Oxidised LDL/LDL-cholesterol ratio and coronary artery calcification in haemodialysis patients
    Asamiya, Y.
    Yajima, A.
    Tsuruta, Y.
    Otsubo, S.
    Nitta, K.
    [J]. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2013, 23 (07) : 619 - 627
  • [3] Bempedoic Acid: A New Tool for LDL-Cholesterol Control in Patients with Coronary Artery Disease
    Bilato, Claudio
    Sesti, Giorgio
    Averna, Maurizio
    [J]. REVIEWS IN CARDIOVASCULAR MEDICINE, 2022, 23 (05)
  • [4] Comparison between small dense LDL-cholesterol and LDL-cholesterol to predict coronary events in stable coronary heart disease
    Yokota, Yuuya
    Koba, Shinji
    Tsunoda, Fumiyoshi
    Ban, Yoshihisa
    Sato, Takayuki
    Shoji, Makoto
    Suzuki, Leroshi
    Katagiri, Takashi
    [J]. NEW FRONTIERS IN LIFESTYLE-RELATED DISEASES, 2008, : 147 - 153
  • [5] LDL-Cholesterol Is Not the Only Clinically Relevant Biomarker for Coronary Artery Disease or Acute Coronary Syndrome
    Field, Patrick A.
    Vasan, Ramachandran S.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 104 (02) : 232 - 234
  • [6] Triglyceride levels predict coronary artery disease prevalence only in patients with low ldl-cholesterol
    Wanitschek, M.
    Suessenbacher, A.
    Doerler, J.
    Pachinger, O.
    Ulmer, H.
    Alber, H. F.
    [J]. EUROPEAN HEART JOURNAL, 2010, 31 : 646 - 647
  • [7] LDL-CHOLESTEROL AS A DETERMINANT OF CORONARY HEART-DISEASE
    HUNNINGHAKE, D
    [J]. CLINICAL THERAPEUTICS, 1990, 12 (05) : 370 - 375
  • [8] LDL-cholesterol is a major determinant of endothelial dysfunction and oxidative stress in patients with coronary artery disease
    Hamilton, CA
    Al-Benna, S
    McClure, JD
    McGrane, DJ
    Zimmerli, LU
    Delles, C
    Rogers, PN
    Berg, GA
    Ford, I
    Dominiczak, AF
    [J]. HYPERTENSION, 2005, 46 (04) : 826 - 826
  • [9] Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol
    Laaksonen, Reijo
    Ekroos, Kim
    Sysi-Aho, Marko
    Hilvo, Mika
    Vihervaara, Terhi
    Kauhanen, Dimple
    Suoniemi, Matti
    Hurme, Reini
    Maerz, Winfried
    Scharnagl, Hubert
    Stojakovic, Tatjana
    Vlachopoulou, Efthymia
    Lokki, Marja-Liisa
    Nieminen, Markku S.
    Klingenberg, Roland
    Matter, Christian M.
    Hornemann, Thorsten
    Juni, Peter
    Rodondi, Nicolas
    Raber, Lorenz
    Windecker, Stephan
    Gencer, Baris
    Pedersen, Eva Ringdal
    Tell, Grethe S.
    Nygard, Ottar
    Mach, Francois
    Sinisalo, Juha
    Luscher, Thomas F.
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 (25) : 1967 - 1976
  • [10] LDL-cholesterol: A risk factor for coronary artery disease - From epidemiology to clinical trials
    Werner, RM
    Pearson, TA
    [J]. CANADIAN JOURNAL OF CARDIOLOGY, 1998, 14 : 3B - 10B
12345